Clinical Trials Logo

Nerve Conduction clinical trials

View clinical trials related to Nerve Conduction.

Filter by:
  • None
  • Page 1

NCT ID: NCT05521737 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

EA&DPN
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This is a controlled clinical trial with the aim to study the effects of electroacupuncture on neuropathic pain reduction, quality of life and changes in sensory and motor nerve conduction velocity in patients with type 2 diabetes mellitus, beneficiaries of the familiar medical centers 20, 40 and 41 of the Instituto Mexicano del Seguro Social, at north of Mexico City, in colaboration with the human acupuncture specialty of the Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico.

NCT ID: NCT04457531 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy

Start date: October 26, 2020
Phase: Early Phase 1
Study type: Interventional

Based on network pharmacology, Liuweiluobi Granule was screened to treat diabetes peripheral neuropathy with deficiency of the spleen and kidney and stasis-heat syndrome.In the preliminary animal experiment, it suggested that this granule had a significant protective effect on the peripheral motor nerves of diabetic peripheral neuropathy and the effect of anti-inflammation, and the prescription did not induce the death of zebrafish at a concentration of 1000 ug/mL, without any obvious toxicity. This study aims to evaluate the efficacy of Liuweiluobi Granule in improving neurotransmission function in patients with diabetic peripheral neuropathy through a pilot, randomized controlled study.

NCT ID: NCT01208545 Active, not recruiting - Chemotherapy Clinical Trials

Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs

Start date: July 2008
Phase: N/A
Study type: Observational

The study hypothesis is that changes in serially obtained nerve conduction study data obtained every 3-4 weeks in cancer patients receiving chemotherapy can be used to predict the development of a clinically significant / disabling drug induced neuropathy six and twelve months following the start of treatment. Patients with breast cancer, colon cancer, gastroesophageal cancer, and non-Hodgkins lymphoma will be enrolled. Six lower extremity nerves--three in each leg--will be electrically stimulated and their responses recorded at three to four week intervals coinciding with patient's scheduled chemotherapy.

NCT ID: NCT01022437 Completed - Numbness Clinical Trials

Geranium Oil and Its Components for the Relief of Numbness-OB 100

Start date: December 2008
Phase: N/A
Study type: Interventional

This study is designed to evaluate the effectiveness of geranium oil and its components in the relief of numbness and the restoration of sensations.